Zeocin resistance as a dominant selective marker for transformation and targeted gene deletions in Candida glabrata

被引:10
作者
Alderton, Alex J.
Burr, Ian
Muehlschlegel, Fritz A.
Tuite, Mick F. [1 ]
机构
[1] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England
[2] Pfizer Ltd, Pfizer Global Res & Dev, Sandwich Labs, Antiinfect, Sandwich CT13 9NJ, Kent, England
关键词
Zeocin; gene disruption; Candida glabrata;
D O I
10.1111/j.1439-0507.2006.01271.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Many of the genetic tools used to generate gene knockouts in Candida glabrata exploit auxotrophic markers but this is not suitable for use with clinical strains. Antibiotic resistance markers, however, allow one to target genes to be deleted without any prior genetic manipulation of clinical isolates. Such antibiotic selection markers have been widely reported for the manipulation of Saccharomyces cerevisiae. However, very few antibiotic resistance markers have been shown to be useful in C. glabrata. Here, we report the use of Zeocin resistance (Zeo(R)), encoded by the ble gene from Streptoalloteichus hindustanus, as a new positive selection marker for the genetic manipulation of C. glabrata including clinical strains that we show are significantly more sensitive to Zeocin than to G418. The potential of the Zeo(R) marker for targeted gene disruption in C. glabrata was confirmed by constructing deletions of the ADE2 in both a laboratory and a clinical strain of C. glabrata, using both short (90 bp) and long (400 bp) homology cassettes.
引用
收藏
页码:445 / 451
页数:7
相关论文
共 34 条
[11]   Candida glabrata:: Review of epidemiology, pathogenesis, and clinical disease with comparison to C-albicans [J].
Fidel, PL ;
Vazquez, JA ;
Sobel, JD .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (01) :80-+
[12]   A new efficient gene disruption cassette for repeated use in budding yeast [J].
Guldener, U ;
Heck, S ;
Fiedler, T ;
Beinhauer, J ;
Hegemann, JH .
NUCLEIC ACIDS RESEARCH, 1996, 24 (13) :2519-2524
[13]   A high-copy-number ADE2-bearing plasmid for transformation of Candida glabrata [J].
Hanic-Joyce, PJ ;
Joyce, PBM .
GENE, 1998, 211 (02) :395-400
[14]   Virulence in Candida species [J].
Haynes, K .
TRENDS IN MICROBIOLOGY, 2001, 9 (12) :591-596
[15]   Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan:: Surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003 [J].
Hsueh, PR ;
Lau, YJ ;
Chuang, YC ;
Wan, JH ;
Huang, WK ;
Shyr, JM ;
Yan, JJ ;
Yu, KW ;
Wu, JJ ;
Ko, WC ;
Yang, YC ;
Liu, YC ;
Teng, LJ ;
Liu, CY ;
Luh, KT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :512-517
[16]   Overproduction of pentose phosphate pathway enzymes using a new CRE-loxP expression vector for repeated genomic integration in Saccharomyces cerevisiae [J].
Johansson, B ;
Hahn-Hägerdal, B .
YEAST, 2002, 19 (03) :225-231
[17]   A yeast by any other name:: Candida glabrata and its interaction with the host [J].
Kaur, R ;
Domergue, R ;
Zupancic, ML ;
Cormack, BP .
CURRENT OPINION IN MICROBIOLOGY, 2005, 8 (04) :378-384
[18]   Isolation of a Candida glabrata centromere and its use in construction of plasmid vectors [J].
Kitada, K ;
Yamaguchi, E ;
Arisawa, M .
GENE, 1996, 175 (1-2) :105-108
[19]   CLONING OF THE CANDIDA-GLABRATA TRP1 AND HIS3 GENES, AND CONSTRUCTION OF THEIR DISRUPTANT STRAINS BY SEQUENTIAL INTEGRATIVE TRANSFORMATION [J].
KITADA, K ;
YAMAGUCHI, E ;
ARISAWA, M .
GENE, 1995, 165 (02) :203-206
[20]   The complete mitochondrial genome sequence of the pathogenic yeast Candida (Torulopsis) glabrata [J].
Koszul, R ;
Malpertuy, A ;
Frangeul, L ;
Bouchier, C ;
Wincker, P ;
Thierry, A ;
Duthoy, S ;
Ferris, S ;
Hennequin, C ;
Dujon, B .
FEBS LETTERS, 2003, 534 (1-3) :39-48